UK Innovation & Science Seed Fund News

Appoints Industry Veteran Glyn Edwards MBE as Chair Oxford, England, 25 April 2022 – MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed. The company also announces the appointment of Glyn Edwards […]

read more

In 2010, UKI2S made a £25,000 pathfinder investment in Tokamak Energy, a spin-out from the Culham Centre for Fusion Energy, to support the commercial development of a fusion neutron device. Tokamak today announces that it has reached a major milestone, reaching 100 million °C, substantiating the use of spherical tokamaks as the optimal route to […]

read more

Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer. Dr McAvoy joins NanoSyrinx from GSK where she was Senior Director in […]

read more

1 2 3 44